Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
0(0%)
Results Posted
38%(3 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_2
2
15%
Ph not_applicable
10
77%
Ph phase_3
1
8%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution13 total trials
Phase 2Efficacy & side effects
2(15.4%)
Phase 3Large-scale testing
1(7.7%)
N/ANon-phased studies
10(76.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

8 of 10 finished

Non-Completion Rate

20.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Completed(8)
Terminated(2)
Other(3)

Detailed Status

Completed8
unknown3
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
88.9%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (15.4%)
Phase 31 (7.7%)
N/A10 (76.9%)

Trials by Status

terminated18%
completed862%
withdrawn18%
unknown323%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
OTHER
Total Trials
13